- Lobbying
- mckesson AND corporation
Lobbying Arrangements Results for 'Mckesson Corporation'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Department of Veterans Affairs Prime Vendor Contract |
McKesson Corporation
|
Michael Copher | |||
Details Medicare payment and coding for clinical laboratory tests; H.R. 4302: Protecting Access to Medicare Act of 2014, P.L. 113-93. |
McKesson Corporation
|
FOLEY HOAG LLP | |||
Details Lobby members of the Pennsylvania Congressional delegation for assistance with funding for health care issues. |
McKesson Corporation
Health care services |
FEINBERG SHOPP ASSOCIATES | |||
Details H.R. 1770, S.2477: Equitable Community Access to Pharmacist Services Act; Clinical trial diversity, health equity; Emergency preparedness and response. PAHPA reauthorization H.R. 4420 and 4421, S... |
McKesson Corporation & affiliates U.S. Oncology and Rx Savings Solutions
|
McKesson Corporation & affiliates U.S. Oncology and Rx Savings Solutions (Formerly McKesson Corp) | |||
Details Legislative and regulatory proposals related to pharmaceutical distribution and veterans health. |
McKesson Corporation
|
DLA Piper LLP (US) | |||
Details Education regarding the Pharmaceutical Prime Vendor contract. |
McKesson Corporation
|
Steve Buyer Group | |||
Details Education regarding the existing Department of Veterans Affairs Pharmaceutical Prime Vendor contract. |
McKesson Corporation
|
ALSTON & BIRD LLP | |||
Details Lobbying issues concentrated on The Transatlantic Trade and Investment Partnership (TTIP)a Propsed agreement between the United States and the European Union. |
State of Maryland (University of Maryland )
|
Davenport McKesson Corporation | |||
Details Issues related to the drug supply chain, transparency and patient access to medicines. |
McKesson Corporation
Medical distribution and health care information technology company. |
W Strategies, LLC | |||
Details Issues around the use of real-time benefit tools, interoperability, data privacy and sharing in healthcare, and healthcare transparency including HR 5378, the Lower Costs, More Transparency Act rel... |
McKesson Corporation
|
Horizon Government Affairs | |||
Details BA Group of London is lobbying the US Congress to start a US , Euro, Asian bank in the Asia pacific region that would guarantee funds to emerging Asian nations looking to start a peaceful nuclear p... |
BA Group of London
|
Davenport McKesson Corporation | |||
Details General and medical device tax issues. |
McKesson Corporation
|
Ernst & Young LLP (Washington Council Ernst & Young) | |||
Details Issues related to COVID medical response,; COVID-19 vaccine distribution,; and health disparities; S.1362 - Pharmacy and Medically Underserved Areas Enhancement Act; H.R. 7667, Food & Drug Amendmen... |
McKesson Corporation
|
Akin, Gump, Strauss, Hauer & Feld | |||
Details Medicare/Medicaid Issues |
McKesson Corporation and its Affiliate U.S. Oncology (formerly US Oncology)
Health care services company |
Liberty Partners Group, LLC | |||
Details General Medicare/Medicaid Issues. Prescription Drug Price Reform. Transparency Requirements. Emergency Preparedness. |
McKesson Corporation
|
Todd Strategy Group | |||
Details Incentives for health information technology; proposed legislation regarding standards for licensure of medical supply distributors; education regarding Appropriate Use Criteria Physician and pharm... |
MCKESSON CORPORATION
|
Van Ness Feldman, LLP | |||
Details Ensuring access to vital pharmacist services. |
Future of Pharmacy Coalition
|
VENN STRATEGIES | |||
Details Advancing H.R.7213, Equitable Community Access to Pharmacist Services Act. |
Future of Pharmacy Coalition LLC
|
ALSTON & BIRD LLP | |||
Details Provide tax legislative and strategic advisory services with respect to legislative proposals to impose higher taxes on income from intangibles. |
Working Group on Intangibles (Informal Coalition)
|
Ernst & Young LLP (Washington Council Ernst & Young) |